Interfering with the expression of CHK1 significantly inhibited proliferation and promoted apoptosis in FLT3-ITD positive AML cells, and increased the sensitivity of AML cells to epigenetic inhibitors. The gene discussed is CHEK1; the disease is acute myeloid leukemia.